PhD
Dr. Masoumeh Khalili is a Postdoctoral Researcher at the International Center for Brain Science, Fujita Health University, Toyoake, Japan. She obtained her Ph.D. in Pharmaceutical Sciences from Mazandaran University of Medical Sciences, Iran, where she conducted pioneering studies on the iron-chelating activity of medicinal plants and mushrooms, particularly Cantharellus cibarius. Before joining Fujita Health University, Dr. Khalili served as a Researcher and Vice Chancellor at the Neuroscience Research Center of Golestan University of Medical Sciences in Iran. During this period, she led multiple research projects investigating the antioxidant and neuroprotective properties of natural compounds and their potential therapeutic roles in neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Currently, at Fujita Health University, her research focuses on Fetal Alcohol Spectrum Disorders (FASD), studying both molecular and behavioral consequences of prenatal alcohol exposure, as well as transgenic and knockout mouse models related to bipolar disorder mechanisms.
Postdoctoral Researcher – Division of Behavioral Neuropharmacology, International Center for Brain Science, Fujita Health University (Japan, 2024–Present)
Researcher & Vice Chancellor – Neuroscience Research Center, Golestan University of Medical Sciences (Iran, 2016–2024)
Graduate Research Assistant – Mazandaran University of Medical Sciences (Iran, 2011–2015)
Supervisor – Ethical Animal Studies Project funded by Iran’s Ministry of Health and Medical Education
Active Member – Animal Ethics Committee, Golestan University of Medical Sciences
Reviewer for numerous international journals, including:
European Journal of Pharmacology
Cellular Physiology and Biochemistry
Natural Product Research
Computers in Biology and Medicine
Current Medicinal Chemistry
International Journal of Peptide Research and Therapeutics